Camber Capital Management LP
- SEC CIK
- 0001444043
- Latest filing
- Aug 14, 2025
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by Camber Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q2 2025 holdings
- Shares (Q2 2025)
- 850,000
- Value
- $14.7M
- % of portfolio
- 2.0%
- Quarters held
- 1
- Since Q2 2025